Oral administration of folic acid and vitamin B12 can lower plasma total homocysteine levels.
口服叶酸和维生素b12可以降低血浆中总高半胱氨酸的水平。
Background: Elevated total homocysteine levels are associated with a higher risk for venous thromboembolism.
背景——升高的总高半胱氨酸水平与较高的静脉血栓栓塞形成风险相关。
Results Mean plasma total homocysteine concentration was reduced by 30% after 1 year of treatment in the groups receiving folic acid and vitamin B12.
结果接受叶酸和维生素b 12治疗的患者一年后血浆总半胱氨酸下降30%。
Plasma total homocysteine, serum aminotransferase activity, and liver malondialdehyde(MDA), superoxidezed dismutase(SOD) and glutathione(GSH) contentswere assayed, Liver histology was also examined.
测定肝匀浆丙二醛（MDA）、超氧化物歧化酶（SOD）和还原型谷胱甘肽（GSH）含量，行肝脏病理组织学检查。
Plasma total homocysteine, serum aminotransferase activity, and liver malondialdehyde(MDA), superoxidezed dismutase(SOD) and glutathione(GSH) contentswere assayed, Liver histology was also examined.
测定肝匀浆丙二醛（MDA）、超氧化物歧化酶（SOD）和还原型谷胱甘肽（GSH）含量，行肝脏病理组织学检查。
应用推荐